Zepp Health(US:ZEPP)2025-08-04 01:30Financial Performance - Q2 2025 - Revenue reached $59.4 million, exceeding the company's guidance[8] - Adjusted net loss attributable to Zepp was -$6.2 million[9] - Units shipped totaled 0.7 million[9] Revenue Breakdown - Revenue from Amazfit-branded wearable products increased by 46.2% compared to Q2 2024[12] - In Q2 2025, Amazfit-branded wearable products accounted for 61.4% of total revenue, while Xiaomi wearable products accounted for 38.6%[12] - In H1 2025, Amazfit-branded wearable products accounted for 60.6% of total revenue, while Xiaomi wearable products accounted for 39.4%[13] Gross Margin - The total gross margin for Q2 2025 was 36.2%[20] - The gross margin for Amazfit-branded products in Q2 2025 was 43.6%[20] - The total gross margin for H1 2025 was 36.6%[26] - The gross margin for Amazfit-branded products in H1 2025 was 41.8%[26] Operating Expenses - Adjusted operating expenses for H1 2025 included G&A, S&M, and R&D[35] - Adjusted operating expenses as a percentage of total revenue for G&A was 10.5%, for S&M was 26.4%, and for R&D was 23.6%[37] Liquidity and Outlook - The company had a liquidity position of $95.3 million in cash and cash equivalents[47] - A share repurchase program of $16.0 million was in place until June 30, 2025[48] - The company expects net revenues to be between $72 million and $76 million for Q3 2025[52]